Filing Details
- Accession Number:
- 0001209191-21-063779
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-09 20:38:46
- Reporting Period:
- 2021-11-05
- Accepted Time:
- 2021-11-09 20:38:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1574700 | Carol Moore | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | Svp Reg. & Quality | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-05 | 110,000 | $3.75 | 289,555 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-11-05 | 110,000 | $7.94 | 181,276 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right to Buy) | Disposition | 2021-11-05 | 110,000 | $0.00 | 110,000 | $3.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-02-28 | No | 4 | M | Direct |
Footnotes
- This transaction was executed pursuant to a 10b5-1 plan.
- The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.81 to $8.05 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- Includes 1,721 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/21.
- One eighth (1/8th) of the shares subject to the Option vested six (6) months after the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vested each month thereafter.
- Not applicable.